Tumors with high-density tumor infiltrating lymphocytes constitute a favorable entity in breast cancer: a pooled analysis of four prospective adjuvant trials-Reference-Cited by-同舟云学术

Tumors with high-density tumor infiltrating lymphocytes constitute a favorable entity in breast cancer: a pooled analysis of four prospective adjuvant trials

Published:2015-10-25 Issue:4 Volume:7 Page:5074-5087
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Kotoula Vassiliki¹²,Chatzopoulos Kyriakos²,Lakis Sotiris²,Alexopoulou Zoi³,Timotheadou Eleni⁴,Zagouri Flora⁵,Pentheroudakis George⁶,Gogas Helen⁷,Galani Eleni⁸,Efstratiou Ioannis⁹,Zaramboukas Thomas⁹,Koutras Angelos¹⁰,Aravantinos Gerasimos¹¹,Samantas Epaminontas¹²,Psyrri Amanda¹³,Kourea Helen¹⁴,Bobos Mattheos²,Papakostas Pavlos¹⁵,Kosmidis Paris¹⁶,Pectasides Dimitrios¹⁷,Fountzilas George²

Affiliation:

1. Department of Pathology, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece

2. Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research, Thessaloniki, Greece

3. Health Data Specialists Ltd, Department of Biostatistics, Athens, Greece

4. Department of Medical Oncology, “Papageorgiou” Hospital, Thessaloniki, Greece

5. Department of Clinical Therapeutics, “Alexandra” Hospital, Athens, Greece

6. Department of Medical Oncology, Ioannina University Hospital, Ioannina, Greece

7. First Department of Medicine, “Laiko” General Hospital, Athens, Greece

8. Second Department of Medical Oncology, “Metropolitan” Hospital, Piraeus, Greece

9. Department of Pathology, “Papageorgiou” Hospital, Thessaloniki, Greece

10. Division of Oncology, Department of Medicine, University Hospital, Patras, Greece

11. Second Department of Medical Oncology, “Agii Anargiri” Cancer Hospital, Athens, Greece

12. Third Department of Medical Oncology, “Agii Anargiri” Cancer Hospital, Athens, Greece

13. Division of Oncology, Second Department of Internal Medicine, Attikon University Hospital, Athens, Greece

14. Department of Pathology, University Hospital of Patras, Rion, Greece

15. Oncology Unit, “Hippokration” Hospital, Athens, Greece

16. Second Department of Medical Oncology, Hygeia Hospital, Athens, Greece

17. Oncology Section, Second Department of Internal Medicine, “Hippokration” Hospital, Athens, Greece

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing the relationship between tumor-infiltrating lymphocytes and PD-L1 expression in triple negative breast cancer: Identifying optimal TILs cut-off value for pathologic reporting;Annals of Diagnostic Pathology;2024-06

2. Progression from ductal carcinoma in situ to invasive breast cancer: molecular features and clinical significance;Signal Transduction and Targeted Therapy;2024-04-03

3. Ten-year clinical outcome, toxicity and compliance of dose-dense sequential adjuvant administration of cyclophosphamide & epirubicin followed by docetaxel in patients with early breast cancer: A hellenic cooperative oncology group observational study (HE 10/10) with concurrent investigation of significance of tumor infiltrating lymphocytes;The Breast;2024-02

4. Prognostic significance of platelet-to-lymphocyte ratio (PLR) in patients with breast cancer treated with neoadjuvant chemotherapy: a meta-analysis;BMJ Open;2023-11

5. The Possible Role of Anti- and Protumor-Infiltrating Lymphocytes in Pathologic Complete Response in Early Breast Cancer Patients Treated with Neoadjuvant Systemic Therapy;Cancers;2023-09-29